ELUCENIA
Skip to content
ELUCENIA

Major questions

Under review

How does resistance arise to a therapy that was initially effective?

A question about changes to the target and alternative pathways.

Editorial updateSeptember 25, 2026
Last scientific reviewScientific review not completed
01Available sources

Starting point

According to the NCI, resistance to targeted therapies can involve changes to the target or growth mechanisms that do not depend on it.

Sources for this section
02Under scientific review

What to investigate

How can the mechanism present in each tumor context and at different times during treatment be identified?

Sources for this section

LIMITATIONS AND CONTEXT

The scope of this reading

  • The source describes general mechanisms. This edition does not include a systematic comparison of mechanisms or interventions to overcome them.
  • A systematic review of supporting and opposing evidence has not yet been completed; the initial source selection is not exhaustive.

ORIGINAL READING

References and sources

  1. Targeted Therapy to Treat CancerNational Cancer Institute / NIH
  2. National Cancer Institute

What would you like to understand?

Search brings together public editorial content and tools. Results retain their review status.